Breast conserving therapy shows survival benefit compared to mastectomy in early-stage patients with hormone receptor positive disease

When factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone-receptor positive disease, according to research.

Read the whole article on Science Daily

More from Science Daily